Listed

Fortress Biotech, Inc.: Form 10-K/A for the period ended Dec 31, 2020

Filed with the SEC on Apr 9, 2021 and accepted by EDGAR at Apr 9, 2021, 17:29 ET.

Share

Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2020-01-01 to 2020-12-31$45.6mus-gaap:Revenues
Cost of revenue12 months2020-01-01 to 2020-12-31$14.6mus-gaap:CostOfGoodsAndServicesSold
Research and development12 months2020-01-01 to 2020-12-31$64.1mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative12 months2020-01-01 to 2020-12-31$61.2mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2020-01-01 to 2020-12-31−$94.3mus-gaap:OperatingIncomeLoss
Income tax12 months2020-01-01 to 2020-12-31$136.0kus-gaap:IncomeTaxExpenseBenefit
Net income12 months2020-01-01 to 2020-12-31−$46.5mus-gaap:NetIncomeLoss
Diluted EPS12 months2020-01-01 to 2020-12-31−$0.65us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2020-01-01 to 2020-12-31−$83.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2020-01-01 to 2020-12-31$1.9mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid12 months2020-01-01 to 2020-12-31$237.0kus-gaap:PaymentsOfDividendsCommonStock
Share repurchases12 months2020-01-01 to 2020-12-31$70.0kus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2020-12-31$233.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-12-31$261.6mus-gaap:AssetsCurrent
Total assetsAt period end2020-12-31$328.8mus-gaap:Assets
Current liabilitiesAt period end2020-12-31$48.0mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-12-31$131.8mus-gaap:Liabilities
Long-term debtAt period end2020-12-31$51.7mus-gaap:LongTermDebt
Shareholders' equityAt period end2020-12-31$100.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001558370-21-004130. Last ingested by Listed: Nov 14, 2026, 11:27 ET. Listed shows no prices and gives no investment advice.